1. Home
  2. TONT vs MNOV Comparison

TONT vs MNOV Comparison

Compare TONT & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TONT

Graf Global Corp. Class A ordinary shares

SELL

Current Price

$10.98

Market Cap

154.5M

Sector

N/A

ML Signal

SELL

Logo Medicinova Inc

MNOV

Medicinova Inc

N/A

Current Price

$1.27

Market Cap

137.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TONT
MNOV
Founded
2021
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
154.5M
137.8M
IPO Year
2024
2004

Fundamental Metrics

Financial Performance
Metric
TONT
MNOV
Price
$10.98
$1.27
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $8.25
AVG Volume (30 Days)
★ 145.6K
45.6K
Earning Date
11-20-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $2,360,807.00
Revenue This Year
N/A
$78.20
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 194.15
52 Week Low
$10.81
$1.22
52 Week High
$11.17
$3.90

Technical Indicators

Market Signals
Indicator
TONT
MNOV
Relative Strength Index (RSI) 53.08 32.50
Support Level N/A N/A
Resistance Level N/A $1.44
Average True Range (ATR) 0.02 0.07
MACD 0.00 0.00
Stochastic Oscillator 15.22 6.94

Price Performance

Historical Comparison
TONT
MNOV

About TONT Graf Global Corp. Class A ordinary shares

Graf Global Corp is a blank check company.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

Share on Social Networks: